Literature DB >> 20668461

Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease.

Mun-Gwan Hong1, Andrey Alexeyenko, Jean-Charles Lambert, Philippe Amouyel, Jonathan A Prince.   

Abstract

We developed and implemented software for the analysis of genome-wide association studies in the context of biological pathway enrichment and have here applied our algorithm to the study of Alzheimer disease (AD). Using genome-wide association data in a large French population, we observed a highly significant enrichment of genes involved in intracellular protein transmembrane transport, including several mitochondrial proteins and nucleoporins. An intriguing aspect of these findings is the implication that TOMM40, the channel-forming subunit of the translocase of the mitochondrial outer membrane complex, and a gene generally considered to be indiscernible from APOE because of linkage disequilibrium, may itself contribute to Alzheimer pathology. Results provide an indication that protein trafficking, in particular across the nuclear and mitochondrial membranes, may contribute to risk for AD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20668461     DOI: 10.1038/jhg.2010.92

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  30 in total

Review 1.  Power and pitfalls of the genome-wide association study approach to identify genes for Alzheimer's disease.

Authors:  Richard Sherva; Lindsay A Farrer
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

2.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.

Authors:  Carlos Cruchaga; Petra Nowotny; John S K Kauwe; Perry G Ridge; Kevin Mayo; Sarah Bertelsen; Anthony Hinrichs; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Arch Neurol       Date:  2011-08

3.  TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease.

Authors:  Valerie Valant; Brendan T Keenan; Christopher D Anderson; Joshua M Shulman; William J Devan; Alison M Ayres; Kristin Schwab; Joshua N Goldstein; Anand Viswanathan; Steven M Greenberg; David A Bennett; Philip L De Jager; Jonathan Rosand; Alessandro Biffi
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

Review 4.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18

Review 5.  APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease.

Authors:  Andrew B Wolf; Richard J Caselli; Eric M Reiman; Jon Valla
Journal:  Neurobiol Aging       Date:  2012-11-16       Impact factor: 4.673

6.  TOMM40 rs2075650 may represent a new candidate gene for vulnerability to major depressive disorder.

Authors:  Martyn McFarquhar; Rebecca Elliott; Shane McKie; Emma Thomas; Darragh Downey; Krisztina Mekli; Zoltan G Toth; Ian M Anderson; J F William Deakin; Gabriella Juhasz
Journal:  Neuropsychopharmacology       Date:  2014-01-29       Impact factor: 7.853

7.  Alzheimer's Disease Variants with the Genome-Wide Significance are Significantly Enriched in Immune Pathways and Active in Immune Cells.

Authors:  Qinghua Jiang; Shuilin Jin; Yongshuai Jiang; Mingzhi Liao; Rennan Feng; Liangcai Zhang; Guiyou Liu; Junwei Hao
Journal:  Mol Neurobiol       Date:  2016-01-09       Impact factor: 5.590

8.  Genome-wide pathway analysis of a genome-wide association study on Alzheimer's disease.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Neurol Sci       Date:  2014-07-19       Impact factor: 3.307

Review 9.  Targeting protein aggregation for the treatment of degenerative diseases.

Authors:  Yvonne S Eisele; Cecilia Monteiro; Colleen Fearns; Sandra E Encalada; R Luke Wiseman; Evan T Powers; Jeffery W Kelly
Journal:  Nat Rev Drug Discov       Date:  2015-09-04       Impact factor: 84.694

10.  Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative.

Authors:  Shashwath A Meda; Mary Ellen I Koran; Jennifer R Pryweller; Jennifer N Vega; Tricia A Thornton-Wells
Journal:  Neurobiol Aging       Date:  2012-10-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.